Pharmacoeconomic study of rivaroxaban and acetylsalicylic acid combination use in patients with coronary artery disease and/or peripheral artery disease
Aim. Comparative assessment of the economic results of rivaroxaban/acetylsalicylic acid (ASA) combination and ASA monotherapy use in patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD). Material and methods. Based on the results of a large international multicenter, pl...
Saved in:
| Main Authors: | N. V. Pogosova, A. V. Panov, A. Yu. Kulikov, V. G. Serpik, V. A. Kulikov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2019-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3584 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization
by: Min Lu, et al.
Published: (2025-01-01) -
Peripheral Arterial Disease
by: A.T.O. Abdool-Carrim
Published: (2004-09-01) -
Comparative clinical and laboratory study of rivaroxaban and its generic forms in patients with stable coronary artery disease
by: N. V. Lomakin, et al.
Published: (2025-03-01) -
Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities
by: article Editorial
Published: (2019-07-01) -
Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?
by: O. L. Barbarash, et al.
Published: (2020-09-01)